NEW YORK (GenomeWeb) — Thermo Fisher Scientific and NX Prenatal said today that they have partnered on the development of mass spectrometry-based proteomics assays for adverse pregnancy outcomes.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.
This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.